Facial Plast Surg 2012; 28(03): 288-293
DOI: 10.1055/s-0032-1312695
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Facial Filler and Neurotoxin Complications

Kartik Nettar
1   The Maas Clinic for Aesthetic and Facial Plastic Surgery, University of California, San Francisco, California
,
Corey Maas
1   The Maas Clinic for Aesthetic and Facial Plastic Surgery, University of California, San Francisco, California
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2012 (online)

Abstract

Botulinum neuromodulators and injectable dermal fillers have become part of the armamentarium in the treatment of facial aging. Their successful use requires a fundamental knowledge of anatomy and physiology and a sound understanding of their risks and complications. Although neuromodulators and fillers continue to demonstrate a strong record of safety, several notable risks exist.

 
  • References

  • 1 2010 Quick Facts: Cosmetic Plastic Surgery Demographic Trends. American Society of Plastic Surgery Report of the 2010 Plastic Surgery Statistics
  • 2 Maas CS. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face. Facial Plast Surg Clin North Am 2006; 14: 241-245
  • 3 MacDonald M, Spiegel J, Maas CS. Glabellar anatomy: the anatomic basis for BTox therapy. Arch Otolaryngol Head Neck Surg 1998; 124: 1315-1320
  • 4 Loos BM, Maas CS. Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin North Am 2003; 11: 439-443
  • 5 Moy R, Maas C, Monheit G, Huber MB ; Reloxin Investigational Group. Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines. Arch Facial Plast Surg 2009; 11: 77-83
  • 6 Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol 2005; 6: 141-150
  • 7 Cho SB, Lee SJ, Kang JM, Kim YK, Ryu DJ, Lee JH. Effective treatment of a injected hyaluronic acid-induced Tyndall effect with a 1064-nm Q-switched Nd:YAG laser. Clin Exp Dermatol 2009; 34: 637-638
  • 8 Weinberg MJ, Solish N. Complications of hyaluronic acid fillers. Facial Plast Surg 2009; 25: 324-328
  • 9 Bailey SH, Cohen JL, Kenkel JM. Etiology, prevention, and treatment of dermal filler complications. Aesthet Surg J 2011; 31: 110-121
  • 10 Dinehart SM, Henry L. Dietary supplements: altered coagulation and effects on bruising. Dermatol Surg 2005; 31 (7 Pt 2) 819-826 ; discussion 826
  • 11 Seeley BM, Denton AB, Ahn MS, Maas CS. Effect of homeopathic Arnica montana on bruising in face-lifts: results of a randomized, double-blind, placebo-controlled clinical trial. Arch Facial Plast Surg 2006; 8: 54-59
  • 12 Maas CS, Yu KCY, Egan K. Neuromodulators and injectable soft tissue substitutes. In: Papel I, ed. Facial Plastic and Reconstructive Surgery. New York: Thieme; 2009: 337-354
  • 13 Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis 2006; 12: 254-270
  • 14 Harmenberg J, Oberg B, Spruance S. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: a literature review. Acta Derm Venereol 2010; 90: 122-130